J-ARC Healthcare Solutions

J-ARC Healthcare Solutions​

J-ARC Healthcare Solutions: A Centre of Excellence for Real World Evidence

Actu-Real Inc. and Jehangir Clinical Development Centre (JCDC), have signed a collaboration agreement on 24th February 2022 to further research based on Real-World Evidence (RWE). This initiative will be called J-ARC Healthcare Solutions.

Through this collaboration, Actu-Real and JCDC will focus on collecting and analyzing real world data (RWD) generated from routine clinical practice to promote evidence-based clinical, economic and regulatory decisions. The requirements of real-world or observational studies with respect to design, systems and processes are often different from those of randomized clinical trials. J-ARC’s experience across the continuum of clinical development and post-approval research, its efficient global delivery model and best-in-class expertise in design, conduct and analysis places it in a unique position to provide fit-for-purpose solutions for such studies. The scientific and research community including biotech, pharma, research universities and healthcare companies will benefit from this collaboration.

Regulatory agencies across the world including the United States Food and Drug Administration (FDA) already use Real World Evidence to monitor post-market safety and adverse events and to make regulatory decisions. The widespread use of mobile devices and electronic health records to gather and store huge amounts of health-related data facilitates such studies further. In addition, J-ARC’s strong execution and advanced analytical capabilities will enable insightful solutions.

India has an important role to play in medical R&D and innovation. Such partnerships will accelerate India’s contribution by creating an enabling ecosystem where stakeholders are able to provide thought leadership and direction to innovators to create commercially viable projects. “This joint initiative aligns with Actu-Real’s mission to enable better results through evidence-based decisions in healthcare and our vision to implement an outcomes-based approach to healthcare access”, said Dr. Chitra Lele, President and founder of Actu-Real, Inc. Prior to founding Actu-Real, Dr. Chitra was part of the founding team of Sciformix which was acquired by Covance (Lab Corp) in 2018. Dr. Pierre Etienne, CMO and co-founder of Actu-Real added that “This collaboration will offer well-crafted solutions to all stakeholders of real-world research.”

“JCDC is a world class research center which is nationally and internationally recognized” said Mr. Jehangir H.C. Jehangir, Chairman of JCDC. Mr. Pathik Divate CEO of JCDC further added, “We are excited about our collaboration with Actu-Real that will facilitate meaningful research and strengthen our abilities to improve health”.

About Actu-Real, Inc.

Actu-Real’s mission is to enable evidence-based decisions in healthcare. Our differentiation is our strong cross-functional expertise across clinical development, RWE, HEOR, market access, statistics, data sciences, actuarial science and technology, along with rich industry experience and leadership experience of strategy and operations in a global and cross-cultural model.
We offer solutions and services to help pharmaceutical companies, payers and providers optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization.